{"id":"W2593027991","doi":"10.1002/cncr.30657","title":"Quality of life with cediranib in relapsed ovarian cancer: The <scp>ICON</scp>6 phase 3 randomized clinical trial","year":2017,"lang":"en","type":"article","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"Medical Research Council; Canadian Cancer Society Research Institute; Cancer Research UK; Cancer Australia; AstraZeneca","keywords":"Medicine; Internal medicine; Chemotherapy; Quality of life (healthcare); Randomized controlled trial; Clinical endpoint; Randomization; Clinical trial; Oncology; Cancer; Surgery","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003042567,0.0009473162,0.001878754,0.0003199348,0.0004062738,0.0008682684,0.000625403,0.001286278,0.004425268],"category_scores_gemma":[0.002396408,0.0003222275,0.001964752,0.0004406905,0.0007644854,0.0004185572,0.0003654283,0.002143241,0.0003774903],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009013214,"about_ca_system_score_gemma":0.001485913,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009526781,"about_ca_topic_score_gemma":0.002274929,"domain_scores_codex":[0.9987237,0.0009184213,0.00005948768,0.0000959262,0.0001042469,0.00009810722],"domain_scores_gemma":[0.9985204,0.0004277235,0.0004414939,0.0001074124,0.00008816609,0.0004146916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9793909,0.003473055,0.001471064,0.000389243,0.0007228189,0.00002654167,0.00002412547,0.0003593982,0.0008852894,0.00007913577,0.0007855172,0.01239286],"study_design_scores_gemma":[0.962429,0.03328893,0.002809734,0.00002803649,0.0003141671,0.00002871453,0.00000684709,0.000388208,0.0001688659,0.00008682904,0.0004439431,0.000006785505],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848256,0.006633522,0.0004995783,0.0008911664,0.0003006228,0.003961584,0.001026052,0.0000735984,0.001788361],"genre_scores_gemma":[0.9845805,0.002819447,0.001734694,0.001166663,0.0003262807,0.006414135,0.001551663,0.00001515947,0.001391486],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004425268,"threshold_uncertainty_score":0.01609081,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1166912492270821,"score_gpt":0.4506985208661173,"score_spread":0.3340072716390352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}